Switching from an SSRI to an SNRI typically involves gradually tapering off the SSRI under a doctor’s guidance and starting the SNRI at a low dose. Switching from a selective serotonin reuptake ...

Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of disability and low quality of life. One in every three people suffering from MDD ...

Esketamine combined with a serotonin-norepinephrine reuptake inhibitor (SNRI) for treatment-resistant depression (TRD) was linked to significantly lower rates of several adverse outcomes than ...

Recent studies have attempted to address this question. Various claims have been made about the dual-acting antidepressants, including: (1) they result in a higher remission rate; (2) they have a more ...

While some may be considered preferred options, the drug selection can vary based on your symptoms, treatment history, and co-existing psychological disorders. There are three basic molecules, known ...

Misperceptions about antidepressants can increase stigma and prevent people from getting much-needed care. Here’s what ...

The announcement came earlier this week. On June 11, the European Medicines Agency formally declared that it was recognizing Post-SSRI Sexual Dysfunction (PSSD) as a medical condition that can outlast ...

Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, disruptions in sleep and/or eating habits, as well as a loss of motivation and ...